BDSX Competitors & Alternatives
Compare Biodesix Inc with similar stocks in the same industry
Diagnostics & Research
BDSX
Main Stock$27.33
Tradestie Score
38
Market Cap
$61.36M
Revenue Growth
0.3%
Analyst Upside
+36.6%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$17.78
|
$1.13B | - | 33 | Compare |
|
CDNA
CareDx, Inc.
|
$66.23
|
$798.40M | 30.8 | 32 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$21.30
|
$719.31M | - | 48 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$35.26
|
$667.77M | - | 43 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$16.17
|
$612.76M | - | 62 | Compare |
|
XGN
Exagen Inc. Common Stock
|
$7.89
|
$241.60M | - | 50 | Compare |
|
ALGS
Aligos Therapeutics, Inc. Common Stock
|
$5.50
|
$71.53M | - | 45 | Compare |
|
AFIB
AFIB
|
- | - | - | - | Compare |
|
DMRA
DMRA
|
$20.23
|
- | - | 51 | Compare |
|
NMAD
NMAD
|
$3.86
|
- | - | 49 | Compare |
More BDSX Analysis
Data updated: Oct 01, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry